ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
34.74
+0.37 (1.08%)
Jun 30, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed a quorum and proceeded virtually, electing three directors for terms ending in 2029 and ratifying PricewaterhouseCoopers LLP as auditor for 2026. No questions were received from stockholders during the Q&A session.